Across tumours with pathogenic germline mutations there was a significant association between MSH6 loss and MSS classification (p = 0.028); isolated MSH6 loss was found in seven out of the eight tumours classified as MSS by either MSI assay, compared to four out of the twelve classified as MSI-H by both (Table 3). The gene discussed is MSH6; the disease is neoplasm.